Cargando…

Informal caregivers experience of supplemental oxygen in pulmonary fibrosis

BACKGROUND: Patients prescribed supplemental oxygen (O(2)) therapy face challenges as they adjust to being constantly “tethered” to an oxygen delivery device. Informal caregivers (ICs) of patients with pulmonary fibrosis (PF) face their own, often overlooked hardships when O(2) is brought into their...

Descripción completa

Detalles Bibliográficos
Autores principales: Graney, Bridget A., Wamboldt, Frederick S., Baird, Susan, Churney, Tara, Fier, Kaitlin, Korn, Marjorie, McCormick, Mark, Vierzba, Thomas, Swigris, Jeffrey J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494136/
https://www.ncbi.nlm.nih.gov/pubmed/28668090
http://dx.doi.org/10.1186/s12955-017-0710-0
_version_ 1783247627080433664
author Graney, Bridget A.
Wamboldt, Frederick S.
Baird, Susan
Churney, Tara
Fier, Kaitlin
Korn, Marjorie
McCormick, Mark
Vierzba, Thomas
Swigris, Jeffrey J.
author_facet Graney, Bridget A.
Wamboldt, Frederick S.
Baird, Susan
Churney, Tara
Fier, Kaitlin
Korn, Marjorie
McCormick, Mark
Vierzba, Thomas
Swigris, Jeffrey J.
author_sort Graney, Bridget A.
collection PubMed
description BACKGROUND: Patients prescribed supplemental oxygen (O(2)) therapy face challenges as they adjust to being constantly “tethered” to an oxygen delivery device. Informal caregivers (ICs) of patients with pulmonary fibrosis (PF) face their own, often overlooked hardships when O(2) is brought into their home and added to their lives. Our aim was to understand the multiple effects of supplemental oxygen therapy on ICs of patients with PF. METHODS: We conducted single, semi-structured telephone interviews with twenty ICs of patients with PF who were using O(2) for at least 8 months. We performed a qualitative, content analysis based in grounded theory to examine data across subjects. RESULTS: ICs initially reacted to O(2) with trepidation and sadness as they came to recognize the changes it would cause in the lives of their patient-loved one (PLO). ICs recognized both beneficial and negative effects of O(2) on their PLOs. ICs also realized that O(2) created significant changes in their own lives, including introducing new roles and responsibilities for them, altering their home environments and significantly impacting their relationships with their PLOs. Although O(2) was a tangible and constant reminder of disease progression, over time ICs were able to adapt and accept their new lives with O(2). CONCLUSION: ICs of patients with PF experience many life changes when their PLO is prescribed O(2). Having O(2) prescribers anticipate and recognize these challenges provides an opportunity to give support and guidance to ICs of PF patients who require O(2) in the hopes of limiting the negative impact of O(2) on their lives. TRIAL REGISTRATION: Clinicaltrials.gov, registration number NCT01961362. Registered 9 October 2013. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12955-017-0710-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5494136
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54941362017-07-05 Informal caregivers experience of supplemental oxygen in pulmonary fibrosis Graney, Bridget A. Wamboldt, Frederick S. Baird, Susan Churney, Tara Fier, Kaitlin Korn, Marjorie McCormick, Mark Vierzba, Thomas Swigris, Jeffrey J. Health Qual Life Outcomes Research BACKGROUND: Patients prescribed supplemental oxygen (O(2)) therapy face challenges as they adjust to being constantly “tethered” to an oxygen delivery device. Informal caregivers (ICs) of patients with pulmonary fibrosis (PF) face their own, often overlooked hardships when O(2) is brought into their home and added to their lives. Our aim was to understand the multiple effects of supplemental oxygen therapy on ICs of patients with PF. METHODS: We conducted single, semi-structured telephone interviews with twenty ICs of patients with PF who were using O(2) for at least 8 months. We performed a qualitative, content analysis based in grounded theory to examine data across subjects. RESULTS: ICs initially reacted to O(2) with trepidation and sadness as they came to recognize the changes it would cause in the lives of their patient-loved one (PLO). ICs recognized both beneficial and negative effects of O(2) on their PLOs. ICs also realized that O(2) created significant changes in their own lives, including introducing new roles and responsibilities for them, altering their home environments and significantly impacting their relationships with their PLOs. Although O(2) was a tangible and constant reminder of disease progression, over time ICs were able to adapt and accept their new lives with O(2). CONCLUSION: ICs of patients with PF experience many life changes when their PLO is prescribed O(2). Having O(2) prescribers anticipate and recognize these challenges provides an opportunity to give support and guidance to ICs of PF patients who require O(2) in the hopes of limiting the negative impact of O(2) on their lives. TRIAL REGISTRATION: Clinicaltrials.gov, registration number NCT01961362. Registered 9 October 2013. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12955-017-0710-0) contains supplementary material, which is available to authorized users. BioMed Central 2017-07-01 /pmc/articles/PMC5494136/ /pubmed/28668090 http://dx.doi.org/10.1186/s12955-017-0710-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Graney, Bridget A.
Wamboldt, Frederick S.
Baird, Susan
Churney, Tara
Fier, Kaitlin
Korn, Marjorie
McCormick, Mark
Vierzba, Thomas
Swigris, Jeffrey J.
Informal caregivers experience of supplemental oxygen in pulmonary fibrosis
title Informal caregivers experience of supplemental oxygen in pulmonary fibrosis
title_full Informal caregivers experience of supplemental oxygen in pulmonary fibrosis
title_fullStr Informal caregivers experience of supplemental oxygen in pulmonary fibrosis
title_full_unstemmed Informal caregivers experience of supplemental oxygen in pulmonary fibrosis
title_short Informal caregivers experience of supplemental oxygen in pulmonary fibrosis
title_sort informal caregivers experience of supplemental oxygen in pulmonary fibrosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494136/
https://www.ncbi.nlm.nih.gov/pubmed/28668090
http://dx.doi.org/10.1186/s12955-017-0710-0
work_keys_str_mv AT graneybridgeta informalcaregiversexperienceofsupplementaloxygeninpulmonaryfibrosis
AT wamboldtfredericks informalcaregiversexperienceofsupplementaloxygeninpulmonaryfibrosis
AT bairdsusan informalcaregiversexperienceofsupplementaloxygeninpulmonaryfibrosis
AT churneytara informalcaregiversexperienceofsupplementaloxygeninpulmonaryfibrosis
AT fierkaitlin informalcaregiversexperienceofsupplementaloxygeninpulmonaryfibrosis
AT kornmarjorie informalcaregiversexperienceofsupplementaloxygeninpulmonaryfibrosis
AT mccormickmark informalcaregiversexperienceofsupplementaloxygeninpulmonaryfibrosis
AT vierzbathomas informalcaregiversexperienceofsupplementaloxygeninpulmonaryfibrosis
AT swigrisjeffreyj informalcaregiversexperienceofsupplementaloxygeninpulmonaryfibrosis